Northern Europe’s leading fertility group
We are excited and delighted to bring the two groups, The Fertility Partnership and VivaNeo, together under our new brand: “TFP”.
As one TFP, we continue to focus on shaping fertility journeys around people’s lives. Across our clinics, through an expansive network of like-minded, passionate professionals we care about each individual coming through our doors and combine world-class expertise with a drive to innovate to provide people the best possible support on their journey to become or grow a family.
VivaNeo and The Fertility Partnership, two of the leading providers of reproductive medicine in Europe, join forces to create TFP, the largest fertility group in Northern Europe with over 60 fertility centres and clinics in six countries.
The merged group offers an excellent patient experience in 19 clinics in 6 countries and performs ~24,000 cycles of assisted reproduction per year.
Since its inception, the group's focus has been on providing a world-class patient experience, supported by scientific and clinical excellence.
The Fertility Partnership was a leading European provider of fertility services, ultrasound pregnancy screening and hormone treatments, with a presence in the UK and Poland. The group comprised 8 IVF clinics in the UK, 2 IVF clinics in Poland, 88 ultrasound clinics in the UK and an emerging hormone treatment business.
Today it is the largest provider of infertility services in the UK and the third largest in Poland; it also operates the leading independent provider of ultrasound services in the UK.
Viva Neo was a leading European infertility treatment provider with operations in Germany, Austria, the Netherlands and Denmark. The group comprised 9 IVF clinics in four countries, a sperm bank and a blood diagnostic laboratory and dialysis centre in Germany. It holds the number 1 or 2 position in terms of market share in each of its markets. The Group's focus is on world-class patient experience and success rates.
We look forward to moving forward as one united TFP.
We have been pioneering and innovating fertility treatment for more than 35 years. Along the way, we’ve achieved many world firsts, enabling our patients to reap the rewards.
Prof Fleming team first demonstrated that ultrasound could be used to identify and measure follicular growth.
Prof Fleming team first demonstrated GnRH Agonists can be used to blockade LH surge in stimulated cycles. Remains the gold standard today, throughout the world.
TFP Group Clinic has world first PGD pregnancy.
1st CF PDG
TFP Group Clinic has world first PGD pregnancy for cystic fibrosis screening.
1st Cancer PDG
TFP Group Clinic has world first PGD pregnancy for predisposition for cancer.
1st haemophilia PDG
TFP Group Clinic has world first PGD pregnancy for haemophilia.
TFP Group Clinic published: Use of Anti-Mullerian Hormone (AMH) to categorise responses to ovarian stimulation in women undergoing IVF.
1st Pergoveris Baby
TFP Group clinic has 1st baby born through use of new fertility drug Pergoveris.
TFP Group Clinic published: Explanation of how progesterone becomes elevated when LH is suppressed.
TFP Group Clinic published: Identification of new phase in the life-history of human ovarian function.
1st EEVA Conception
TFP Group Clinic has world first conception to birth from EEVA timelapse technology.
1st Kisspeptin Baby
TFP Group Clinic has world first IVF baby using Kisspeptin.
The Fertility Partnership and VivaNeo join forces, creating a pan-European fertility super-network: TFP.